Out-of-hospital thrombolytic therapy during cardiopulmonary resuscitation in refractory cardiac arrest due to acute myocardial infarction

European Journal of Emergency Medicine

Volumn 8, Issue 3, 2001, Pages 241-243

  Duchateau, F X ^a   Preiss, V ^a   Ricard Hibon, A ^a   Chollet, C ^a   Marty, J ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Cardiac arrest; Keywords; Myocardial infarction; Out of hospital; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR;

AMBULATORY CARE; ARTICLE; CASE REPORT; FEMALE; FIBRINOLYTIC THERAPY; HEART ARREST; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; RESUSCITATION; TIME; TREATMENT OUTCOME;

AMBULATORY CARE; CARDIOPULMONARY RESUSCITATION; FEMALE; FIBRINOLYTIC AGENTS; HEART ARREST; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATORS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0035463458     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/00063110-200109000-00015     Document Type: Article

References (14)

1. Cross, S.J., Lee, H.S., Rawles, J.M. et al. (1991). Safety of thrombolysis in association with cardiopulmonary resuscitation. Br. Med. J. 303:1242.
2. Tenaglia, A.N., Califf, R.M., Candela, R.J. et al. (1991). Thrombolytic in patients requiring cardiopulmonary resuscitation. Am. J. Cardiol. 68:1015-1019.
3. Scholz, K.H., Tebbe, U., Hermann, C. et al. (1991). Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am. J. Cardiol. 69:724-728.
4. van Kampen, L.C.M.C., van Leeuwen, G.R. and Verheugt, F.W.A. (1994). Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation. Am. J. Cardiol. 73:953-955.
5. Tiffany, P.A., Schultz, M. and Stueven, H. (1998). Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: outcome of a case series. Ann. Emerg. Med. 31:124-126.
6. Newman, D.H., Greenwald, I. and Callaway, C.W. (2000). Cardiac arrest and the role of thrombolytic. Ann. Emerg. Med. 35:472-480.
7. Ricard-Hibon, A., Chollet, C., Saada, S., Loridant, B. and Marty, J. (1999). A quality control program for acute pain management in out-of-hospital critical care medicine. Ann. Emerg. Med. 34:738-744.
8. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care (2000). Part 6: Advanced cardiovascular life support. Resuscitation 46 (1-3):103-143.
9. Cantineau, J., Lambert, Y., Merckx, P. et al. (1996). End-tidal carbon dioxide during cardiopulmonary resuscitation in humans presenting mostly with asystole: a predictor of outcome. Crit. Care Med. 24:791-796.
10. Newby, K.H., Thompson, T., Stebbins, A. et al. (1998). for the GUSTO investigators. Sustained ventricular arrhythmia in patients receiving thrombolytic therapy: incidence and outcomes. Circulation 98:2567-2573.
11. Berger, P.B., Ruocco, N.A., Ryan, T.J. et al. (1993). Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the thrombolysis in myocardial infarction (TIMI) Phase II Trial. J. Am. Coll. Cardiol. 22:1773-1779.
12. EMIP (The European Myocardial Infarction Project Group (1993). Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N. Engl. J. Med. 329:383-389.
13. Manning, A.S. (1993). The reasons why basic scientists study reperfusion arrhythmias. Cardiovasc. Res. 27:1907.
14. The GUSTO Angiographic Investigators (1993). The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction. N. Engl. J. Med. 329:1615-1622.